{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:06:47Z","timestamp":1772021207064,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.vaccine.2006.09.059","type":"journal-article","created":{"date-parts":[[2006,10,3]],"date-time":"2006-10-03T12:04:53Z","timestamp":1159877093000},"page":"1076-1084","source":"Crossref","is-referenced-by-count":34,"title":["Dengue tetravalent DNA vaccine increases its immunogenicity in mice when mixed with a dengue type 2 subunit vaccine or an inactivated Japanese encephalitis vaccine"],"prefix":"10.1016","volume":"25","author":[{"given":"Jun-ichi","family":"Imoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.09.059_bib1","series-title":"Fields virology","first-page":"1043","article-title":"Flavivirus","author":"Burke","year":"2001"},{"key":"10.1016\/j.vaccine.2006.09.059_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/rmv.324","article-title":"Dengue fever and dengue haemorrhagic fever: challenges of controlling an enemy still at large","volume":"11","author":"Kurane","year":"2001","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2006.09.059_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0966-842X(01)02288-0","article-title":"Epidemic dengue\/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century","volume":"10","author":"Gubler","year":"2002","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2006.09.059_bib4","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(02)11276-1","article-title":"The future of dengue vaccines","volume":"360","author":"Halstead","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.09.059_bib5","first-page":"308","article-title":"Understanding dengue pathogenesis: implications for vaccine design","volume":"83","author":"Stephenson","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2006.09.059_bib6","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.vaccine.2004.11.040","article-title":"Review on flavivirus vaccine development","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.09.059_bib7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4269\/ajtmh.2002.66.264","article-title":"Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses","volume":"66","author":"Sabchareon","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2006.09.059_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/01.inf.0000109289.55856.27","article-title":"Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children","volume":"23","author":"Sabchareon","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2006.09.059_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.2003.69.6_suppl.0690001","article-title":"Progress in development of a live-attenuated, tetravalent dengue virus vaccine by the United States Army Medical Research and Materiel Command","volume":"69","author":"Innis","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2006.09.059_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4269\/ajtmh.2003.69.48","article-title":"Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine","volume":"69","author":"Edelman","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2006.09.059_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4269\/ajtmh.2001.65.159","article-title":"Antibody responses of mice immunized with a tetravalent dengue recombinant protein subunit vaccine","volume":"65","author":"Simmons","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2006.09.059_bib12","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1128\/JVI.76.7.3318-3328.2002","article-title":"Derivation and characterization of a dengue type 1 host range-restricted mutant virus that is attenuated and highly immunogenic in monkeys","volume":"76","author":"Markoff","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.09.059_bib13","doi-asserted-by":"crossref","first-page":"11436","DOI":"10.1128\/JVI.77.21.11436-11447.2003","article-title":"Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development","volume":"77","author":"Huang","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.09.059_bib14","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1128\/JVI.78.9.4761-4775.2004","article-title":"Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates","volume":"78","author":"Guirakhoo","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.09.059_bib15","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1128\/JVI.79.9.5516-5528.2005","article-title":"Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys","volume":"79","author":"Blaney","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.09.059_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.virol.2006.05.005","article-title":"A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques","volume":"353","author":"Raviprakash","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2006.09.059_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3527(00)55001-5","article-title":"DNA vaccines for viral infections: basic studies and applications","volume":"55","author":"Robinson","year":"2000","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2006.09.059_bib18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0065-3527(03)61012-2","article-title":"DNA vaccines for flaviviruses","volume":"61","author":"Putnak","year":"2003","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2006.09.059_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4049\/jimmunol.175.2.633","article-title":"DNA vaccines: progress and challenges","volume":"175","author":"Donnelly","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.09.059_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0065-2660(05)55002-8","article-title":"Human clinical trials of plasmid DNA vaccines","volume":"55","author":"Liu","year":"2005","journal-title":"Adv Genet"},{"key":"10.1016\/j.vaccine.2006.09.059_bib21","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.vaccine.2005.11.002","article-title":"Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice","volume":"24","author":"Konishi","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.09.059_bib22","series-title":"Fields virology","first-page":"991","article-title":"Flaviviridae: the viruses and their replication","author":"Lindenbach","year":"2001"},{"key":"10.1016\/j.vaccine.2006.09.059_bib23","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0264-410X(01)00446-7","article-title":"Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine","volume":"20","author":"Konishi","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.09.059_bib24","first-page":"3","article-title":"The mechanism of naked DNA uptake and expression. Review","volume":"54","author":"Wolff","year":"2005","journal-title":"Adv Genet"},{"key":"10.1016\/j.vaccine.2006.09.059_bib25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1517\/17425247.2.5.829","article-title":"Strategies for DNA vaccine delivery. Review","volume":"2","author":"Alpar","year":"2005","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.vaccine.2006.09.059_bib26","first-page":"23","article-title":"Prime-boost immunization strategies for infectious diseases","volume":"4","author":"McShane","year":"2002","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.vaccine.2006.09.059_bib27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.0105-2896.2004.00138.x","article-title":"Progress in DNA-based heterologous prime-boost immunization strategies for malaria","volume":"199","author":"Moore","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2006.09.059_bib28","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/S0264-410X(03)00028-8","article-title":"Simultaneous immunization with DNA and protein vaccines against Japanese encephalitis or dengue synergistically increases their own abilities to induce neutralizing antibody in mice","volume":"21","author":"Konishi","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.09.059_bib29","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1016\/S0264-410X(03)00376-1","article-title":"Evidence for antigen production in muscles by dengue and Japanese encephalitis DNA vaccines and a relation to their immunogenicity in mice","volume":"21","author":"Konishi","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.09.059_bib30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/vim.2005.18.205","article-title":"Needle-free jet injection of a mixture of Japanese encephalitis DNA and protein vaccines: a strategy to effectively enhance immunogenicity of the DNA vaccine in a murine model","volume":"18","author":"Imoto","year":"2005","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2006.09.059_bib31","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0264-410X(99)00376-X","article-title":"A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice","volume":"18","author":"Konishi","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.09.059_bib32","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1128\/JVI.72.6.4925-4930.1998","article-title":"Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding JE virus premembrane and envelope genes","volume":"72","author":"Konishi","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.09.059_bib33","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1089\/104303401753153965","article-title":"Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine","volume":"12","author":"Biswas","year":"2001","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2006.09.059_bib34","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.1016\/j.vaccine.2006.04.063","article-title":"Immune responses elicited by bacterial minicells capable of simultaneous DNA and protein antigen delivery","volume":"24","author":"Giacalone","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.09.059_bib35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0923-2516(98)80005-8","article-title":"Dengue encephalitis in French Guiana","volume":"149","author":"Hommel","year":"1998","journal-title":"Res Virol"},{"key":"10.1016\/j.vaccine.2006.09.059_bib36","unstructured":"Association for Laboratory Animal Science, editor. Advanced Laboratory Animal Science and Technology. Tokyo, Japan: Adthree; 2004 [in Japanese]."},{"key":"10.1016\/j.vaccine.2006.09.059_bib37","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1016\/S0264-410X(03)00382-7","article-title":"Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice","volume":"21","author":"Konishi","year":"2003","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06010644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06010644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T11:32:39Z","timestamp":1587209559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06010644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0264410X06010644"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.09.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}